Consolidation

(Image: Getty/martince2)

SCOPE 2018

A CRO monopoly? Sponsors frustrated with lack of options

By Melissa Fassbender

With fewer global mid-sized contract research organizations (CRO) through consolidation, some stakeholders are expressing concern that the industry could become a monopoly – “we may be getting there,” one expert said.

GettyImages/maxsattana

Charles River to buy MPI Research for $800m

By Flora Southey

Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.

(Image: iStock/manaemedia)

INC Research/inVentiv now Syneos Health

By Melissa Fassbender

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

GettyImages/dima_sidelnikov

Flexible, agile, niche: How small-sized CROs compete

By Flora Southey

Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.